Candida yeast has been associated with a significant number of systemic infections in humans. The incidence of invasive infections caused by the genus Candida has increased in recent years, becoming the most commonly diagnosed fungal infection in humans. The epidemiology of this pathogen indicates that in the USA it is the fourth most common microorganism isolated from blood cultures, in Europe it is classified among the 10 most frequently recovered pathogens, and worldwide, according to a study carried out in intensive care units, the prevalence of candidemia was 6.9 per 1000 patients. In 2009, a new species of Candida grouped within the Candida haemulonii complex, known as Candida auris, was described after its isolation from the ear secretion of a patient in Japan, from which cases, especially fungemias, have been reported in different countries of the world. In Colombia, from 2013 a series of cases have been presented, especially on the Caribbean coast, associated with the recovery of C. auris, mainly from blood culture samples from patients in intensive care units. The fungemias caused by this species have been associated with high mortality, therapeutic failure, and resistance to the main antifungal families.
|Effective start/end date||1/15/18 → 12/31/20|
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Bogotá D.C.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.